Skip to main content
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1979 Dec;63(12):813–816. doi: 10.1136/bjo.63.12.813

Control of glaucoma by reduced dosage guanethidine-adrenaline formulation.

D E Jones, D A Norton, D J Davies
PMCID: PMC1043633  PMID: 393300

Abstract

The effect of formulations of guanethidine and adrenaline of different composition has been tested in rabbits and in patients with glaucoma. The concentrations of guanethidine and adrenaline used for the rabbits were 5.0% and 1.0%; 2.5% and 0.5%; 1.0% and 0.2%; 0.5% and 0.1%. All except the lowest combination were equally effective in the magnitude of the decrease in intraocular pressure brought about and in their duration of activity. Two formulations containing guanethidine and adrenaline at concentrations of 3.0% and 0.5% and 1.0% and 0.2% respectively (formulated as Ganda drops by Smith and Nephew Pharmaceuticals Ltd) were tested in a blind, cross-over, short-term clinical trial on 20 patients. The drops containing the lower concentration of drugs were as effective as those of higher concentration. These results lead us to believe that most patients who respond to this treatment could be put on a reduced dosage regimen, which should result in a decreased incidence and severity of side effects.

Full text

PDF
813

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gloster J. Guanethidine and glaucoma. Trans Ophthalmol Soc U K. 1974 Jul;94(2):573–577. [PubMed] [Google Scholar]
  2. Hoyng F. J., Dake C. L. The combination of guanethidine 3% and adrenaline 0.5% in 1 eyedrop (GA) in glaucoma treatment. Br J Ophthalmol. 1979 Jan;63(1):56–62. doi: 10.1136/bjo.63.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Jones D. E., Norton D. A., Davies D. J. Low dosage combined adrenaline-guanethidine formulations in the management of chronic simple glaucoma. Trans Ophthalmol Soc U K. 1977 Apr;97(1):192–195. [PubMed] [Google Scholar]
  4. Jones D. E., Norton D. A., Harvey J., Davies D. J. Effect of adrenaline and guanethidine in reducing intraocular pressure in rabbits' eyes. Br J Ophthalmol. 1975 Jun;59(6):304–307. doi: 10.1136/bjo.59.6.304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Mills K. B., Ridgway A. E. A double blind comparison of guanethidine-and-adrenaline drops with 1% adrenaline alone in chronic simple glaucoma. Br J Ophthalmol. 1978 May;62(5):320–323. doi: 10.1136/bjo.62.5.320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Paterson G. D., Paterson G. Drug therapy of glaucoma. Br J Ophthalmol. 1972 Mar;56(3):288–294. doi: 10.1136/bjo.56.3.288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Romano J., Patterson G. Evaluation of a 5% guanethidine and 0.5% adrenaline mixture (Ganda 5.05) and of a 3% guanethidine and 0.5% adrenaline mixture (Ganda 3.05) in the treatment of open-angle glaucoma. Br J Ophthalmol. 1979 Jan;63(1):52–55. doi: 10.1136/bjo.63.1.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Roth J. A. Guanethidine and adrenaline used in combination in chronic simple glaucoma. Br J Ophthalmol. 1973 Jul;57(7):507–510. doi: 10.1136/bjo.57.7.507. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES